Safety and efficacy of atezolizumab plus carboplatin-etoposide (Atezo-CaE) for extensive stage (ES) small cell lung cancer patients
Latest Information Update: 12 Oct 2021
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Sep 2021 Results assessing long-term survival outcomes presented at the 2021 World Conference on Lung Cancer
- 08 Mar 2021 New trial record
- 31 Jan 2021 Results presented at the 2020 World Conference on Lung Cancer